Cargando…
Therapeutic use of red blood cells and platelets derived from human cord blood stem cells
Red blood cells (RBCs) and platelets derived from stem cells are possible solutions to the increasing demand for blood transfusion. Based on the availability of stem cells, their relatively defined differentiation mechanisms, and the massive exploration of induction systems, the generation of RBCs o...
Autores principales: | Xie, Xiaoyan, Yao, Hailei, Han, Xiaoyan, Yue, Wen, Pei, Xuetao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560193/ https://www.ncbi.nlm.nih.gov/pubmed/34724719 http://dx.doi.org/10.1002/sctm.20-0517 |
Ejemplares similares
-
Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges
por: Zhou, Lindsay, et al.
Publicado: (2022) -
Factors Influencing the Efficacy of Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury
por: Purcell, Elisha, et al.
Publicado: (2023) -
Clinical Progress and Preclinical Insights Into Umbilical Cord Blood Transplantation Improvement
por: Sun, Zhongjie, et al.
Publicado: (2022) -
Umbilical cord blood: The promise and the uncertainty
por: Kindwall‐Keller, Tamila L., et al.
Publicado: (2020) -
Liver Sinusoidal Endothelial Cells Promote the Expansion of Human Cord Blood Hematopoietic Stem and Progenitor Cells
por: Li, Huilin, et al.
Publicado: (2019)